MRK — Merck & Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41,518	48,704	59,283	60,115	64,168
Cost of Revenue
Gross Profit	29,935	35,463	42,077	44,200	49,470
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	36,545	36,166	41,338	58,333	44,256
Operating Profit	4,973	12,538	17,945	1,783	19,912
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	5,863	13,879	16,444	1,889	19,936
Provision for Income Taxes
Net Income After Taxes	4,523	12,358	14,526	377	17,133
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	7,067	13,049	14,519	365	17,117
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7,067	13,049	14,519	365	17,117
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.7	6.71	7.3	5.73	9.06
Dividends per Share